Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies

被引:0
作者
Dennis J. Sholler
Lauren Schoene
Tory R. Spindle
机构
[1] Johns Hopkins University School of Medicine,Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences
来源
Current Addiction Reports | 2020年 / 7卷
关键词
Cannabidiol; Cannabis; Clinical trials; Cannabinoids;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:405 / 412
页数:7
相关论文
共 227 条
[1]  
Bonn-Miller MO(2017)Labeling accuracy of cannabidiol extracts sold online Jama 318 1708-1709
[2]  
Loflin MJE(2019)The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids Forensic Sci Int 294 e25-ee7
[3]  
Thomas BF(2018)Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence J Neurol Neurosurg Psychiatry 89 741-753
[4]  
Marcu JP(2016)Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurol 15 270-278
[5]  
Hyke T(2017)Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome N Engl J Med 376 2011-2020
[6]  
Vandrey R(2018)Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome N Engl J Med 378 1888-1897
[7]  
Poklis JL(2016)Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex Epilepsia. 57 1617-1624
[8]  
Mulder HA(2020)CBD (cannabidiol) product attitudes, knowledge, and use among young adults Subst Use Misuse 55 1138-1145
[9]  
Peace MR(2003)Pharmacology of human experimental anxiety Braz J Med Biol Res 36 421-432
[10]  
Stockings E(1993)Effects of ipsapirone and cannabidiol on human experimental anxiety J Psychopharmacol 7 82-88